Duane Boise

MMJ BioPharma Cultivation finds itself at the center of a pivotal legal struggle with the Drug Enforcement Administration (DEA), accusing the agency of significant delays in processing its application to grow marijuana for pharmaceutical research. The company's lawsuit claims these delays have...

The Supreme Court recently ruled in a case Jarkesy versus Securities and Exchange Commission (SEC) that defendants have a right to a jury trial under the Seventh Amendment when facing enforcement actions from federal agencies, writes Vox. While this case considered a hedge fund manager accused of...

The Ninth Circuit Court of Appeals ordered the DEA on Monday to respond within 30 days to the suit arguing the agency has been “dragging their heels” for the approval of the medical marijuana company’s API Bulk Manufacturing Registration. What happened: Cannabis...

Cannabis researcher MMJ International Holdings Corp recently reached a milestone when it officially submitted requested responses to the U.S. Food and Drug Administration (FDA) regarding its cannabis formulation. This submission comes in response to an FDA notification...

Cannabis researcher MMJ International Holdings Corp (MMJ) will sue the DEA over a bulk manufacturing application that was submitted almost five years ago and never processed. Benzinga spoke with MMJ’s president Duane Boise who confirmed that the company will...

Cannabis researcher MMJ International Holdings Corp (MMJ) continues to fight with the Drug Enforcement Administration (DEA) over a bulk manufacturing application that was submitted almost five years ago, and never processed. Megan Sheehan of Sheehan & Associates, representing MMJ,...

MMJ BioPharma Labs, MMJ BioPharma Cultivation and MMJ International Holdings in collaboration with a specialty pharmaceutical soft gelatin manufacturing company, has completed manufacturing of its THC, CBD capsule medicine formulated on compounds found in the cannabis plant. The company will...

A Rhode Island federal judge has referred a suit by cannabis researcher MMJ International Holdings Corp. alleging the Drug Enforcement Administration has delayed processing its application to import and study cannabis, saying the circuit courts are a better venue for the dispute. In an order filed...

MMJ BioPharma Cultivation, a DEA API Bulk Manufacturer applicant to grow marijuana received their advanced precision cultivation equipment. With this innovative cultivation technology MMJ BioPharma Cultivation will be able to reproduce quality strain specific cannabis to meet the DEA's...

MMJ companies are building a center of marijuana excellence in Rhode Island and has filed for FDA sanctioned clinical trials in multiple sclerosis and Huntington's disease. MMJ was awarded the much coveted orphan drug designation from the FDA for its planned Huntington's disease trials, and...

As states legalize marijuana, some as long as 10 years ago, many are beginning to realize the public health and safety implications of a variety of new high-potency products as questions about possible links to psychosis arise.  MMJ BioPharma Labs is positioned to perform...

Megan Sheehan of Sheehan & Associates, Attorneys representing MMJ International Holdings and MMJ BioPharma Cultivation etal, scheduled to execute on clinical trials in Huntington's disease and multiple sclerosis, filed a motion in federal court against the Drug Enforcement Administration,...

Two Rhode Island cannabinoid research laboratories are suing the DEA for standing in the way of what they consider to be the crucial development of pharmaceutical-grade cannabis products for use in clinical trials for the treatment of Multiple Sclerosis and...

MMJ International Holdings, in collaboration with a specialty pharmaceutical solutions company, has been manufacturing gelatin capsule medicines based on compounds found in cannabis. The company will investigate these in clinical trials as potential treatments for multiple sclerosis (MS) and...

MMJ BioPharma Labs recently became one of the only federally authorized labs dedicated to cannabis extraction, research, and development with their approved DEA Analytical Lab Registration for schedule 1-4 drugs. The company's primary focus is on cannabis research and development. MMJ BioPharma...